Lung Cancer
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
News
Fifth COVID shot recommended for patients with cancer
Conference Coverage
Preop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapy
The combination resulted in significantly longer event-free survival.
Conference Coverage
‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC
The finding comes from an analysis of long-term follow-up data from the CodeBreaK100 trial.
Conference Coverage
International group identifies actions to improve lung cancer survival
Experts recommend confirming lung cancer diagnosis within 30 days of referral.
Conference Coverage
Biomarker testing gains momentum in NSCLC
The NCCN recommends biomarker testing for patients with newly diagnosed stage 4 NSCLC.
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
Conference Coverage
Lung cancer in 2030: Expand genotyping
Improve the ability to treat patients based on risk level and expand the use of targeted therapies.
Conference Coverage
Weighing the complexity of pathological response in lung cancer
Future work should aim to standardize pathology assessment.
Conference Coverage
Pembro provides DFS benefit in early NSCLC
But more data are needed to understand the longer-term survival outcomes and the role of PD-L1 as a predictive marker for sensitivity to immune...
